Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): A randomized controlled trial

被引:12
作者
Rickard, Claire M. [1 ,2 ,3 ,4 ]
Larsen, Emily [1 ,2 ,3 ]
Walker, Rachel M. [3 ,4 ]
Mihala, Gabor [3 ,5 ]
Byrnes, Joshua [3 ,5 ]
Saiyed, Masnoon [3 ,5 ]
Cooke, Marie [3 ]
Finucane, Julie [3 ,6 ]
Carr, Peter J. [3 ,7 ]
Marsh, Nicole [1 ,2 ,3 ]
机构
[1] Univ Queensland, Sch Nursing Midwifery & Social Work, Ctr Clin Res, Herston, Qld, Australia
[2] Metro North Hlth, Nursing & Midwifery Res Ctr, Herston Infect Dis Inst, Royal Brisbane & Womens Hosp, Herston, Qld, Australia
[3] Griffith Univ, Sch Nursing & Midwifery, Alliance Vasc Access Teaching & Res Grp, Nathan, Qld, Australia
[4] Princess Alexandra Hosp, Div Surg, Nursing Profess Dev Unit, Buranda, Qld, Australia
[5] Griffith Univ, Ctr Appl Hlth Econ, Sch Med & Dent, Nathan, Qld, Australia
[6] Queen Elizabeth II Hosp, Metro South Hosp & Hlth Serv, Nathan, Qld, Australia
[7] Natl Univ Ireland Galway, Sch Nursing & Midwifery, Galway, Ireland
关键词
RISK-FACTORS; FAILURE; SAFETY; RATES; CARE;
D O I
10.1002/jhm.12995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background One-third of peripheral intravenous catheters (PIVCs) fail from inflammatory or infectious complications, causing substantial treatment interruption and replacement procedures. Objectives We aimed to compare complications between integrated PIVCs (inbuilt extension sets, wings, and flattened bases) and traditional nonintegrated PIVCs. Designs, Settings and Participants A centrally randomized, controlled, superiority trial (with allocation concealment until study entry) was conducted in three Australian hospitals. Medical-surgical patients (one PIVC each) requiring intravenous therapy for >24 h were studied. Main Outcome Measures The primary outcome was device failure (composite: occlusion, infiltration, phlebitis, dislodgement, local, or bloodstream infection). Infection endpoints were assessor-masked. The secondary outcomes were: failure type, first-time insertion success, tip colonization, insertion pain, dwell time, mortality, costs, health-related quality of life, clinician, and patient satisfaction. Results Out of 1759 patients randomized (integrated PIVC, n = 881; nonintegrated PIVC, n = 878), 1710 (97%) received a PIVC and were in the modified intention-to-treat analysis (2269 PIVC-days integrated; 2073 PIVC-days nonintegrated). Device failure incidence was 35% (145 per 1000 device-days) nonintegrated, and 33% (124 per 1000 device-days) integrated PIVCs. Intervention Integrated PIVCs had a significantly lower failure risk (adjusted [sex, infection, setting, site, gauge] hazard ratio [HR]: 0.82 [95% confidence interval, CI: 0.69-0.96], p = .015). The per-protocol analysis was consistent (adjusted HR: 0.80 [95% CI: 0.68-0.95], p = .010). Integrated PIVCs had significantly longer dwell (top quartile >= 95 vs. >= 84 h). Mean per-patient costs were not statistically different. Conclusions PIVC failure is common and complex. Significant risk factors include sex, infection at baseline, care setting, insertion site, catheter gauge, and catheter type. Integrated PIVCs can significantly reduce the burden of PIVC failure on patients and the health system.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 38 条
  • [1] A Randomized Controlled Trial to Compare the Complications of 2 Peripheral Intravenous Catheter-Stabilization Systems
    Bausone-Gazda, Dawn
    Lefaiver, Cheryl A.
    Walters, Shelley-Ann
    [J]. JOURNAL OF INFUSION NURSING, 2010, 33 (06) : 371 - 384
  • [2] Blanco-Mavillard I, 2021, LANCET HAEMATOL, V8, pE637, DOI 10.1016/S2352-3026(21)00206-4
  • [3] Integrated versus nOn-integrated Peripheral inTravenous catheter. Which Is the most effective systeM for peripheral intravenoUs catheter Management? (The OPTIMUM study): randomised controlled trial protocol
    Castillo, Maria Isabel
    Larsen, Emily
    Cooke, Marie
    Marsh, Nicole M.
    Wallis, Marianne C.
    Finucane, Julie
    Brown, Peter
    Mihala, Gabor
    Carr, Peter J.
    Byrnes, Joshua
    Walker, Rachel
    Cable, Prudence
    Zhang, Li
    Sear, Candi
    Jackson, Gavin
    Rowsome, Anna
    Ryan, Alison
    Humphries, Julie C.
    Sivyer, Susan
    Flanigan, Kathy
    Rickard, Claire M.
    [J]. BMJ OPEN, 2018, 8 (05):
  • [4] Short Peripheral Catheter Performance Following Adoption of Clinical Indication Removal
    DeVries, Michelle
    Strimbu, Kathryn
    [J]. JOURNAL OF INFUSION NURSING, 2019, 42 (02) : 81 - 90
  • [5] Drummond MF, 2015, Methods for the economic evaluation of health care programmes
  • [6] Results of a multi-faceted educational intervention to prevent peripheral venous catheter-associated bloodstream infections
    Garcia-Gasalla, M.
    Arrizabalaga-Asenjo, M.
    Collado-Giner, C.
    Ventayol-Aguilo, L.
    Socias-Mir, A.
    Rodriguez-Rodriguez, A.
    Perez-Seco, M-C
    Payeras-Cifre, A.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2019, 102 (04) : 449 - 453
  • [7] Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study
    Gonzalez Lopez, J. L.
    Arribi Vilela, A.
    Fernandez del Palacio, E.
    Olivares Corral, J.
    Benedicto Marti, C.
    Herrera Portal, P.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2014, 86 (02) : 117 - 126
  • [8] Section One: Infusion Therapy Practice
    不详
    [J]. JOURNAL OF INFUSION NURSING, 2021, 44 : S13 - S42
  • [9] Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial
    Guenezan, Jeremy
    Marjanovic, Nicolas
    Drugeon, Bertrand
    Neill, Roderick O.
    Liuu, Evelyne
    Roblot, France
    Palazzo, Paola
    Bironneau, Vanessa
    Prevost, Frederique
    Paul, Julie
    Pichon, Maxime
    Boisson, Matthieu
    Frasca, Denis
    Mimoz, Olivier
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (07) : 1038 - 1048
  • [10] Hadaway L C, 1999, Nursing, V29, P41